These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Varicella-zoster vaccine: the bad news may be good. Mills J Nat Med; 2000 Apr; 6(4):381-2. PubMed ID: 10742140 [No Abstract] [Full Text] [Related]
5. Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax. Kim JI; Jung GS; Kim YY; Ji GY; Kim HS; Wang WD; Park HS; Park SY; Kim GH; Kwon SN; Lee KM; Ahn JH; Yoon Y; Lee CH Virol J; 2011 Dec; 8():547. PubMed ID: 22176950 [TBL] [Abstract][Full Text] [Related]
6. Live attenuated varicella vaccine. Gershon AA Pediatr Ann; 1984 Sep; 13(9):653-6. PubMed ID: 6093030 [No Abstract] [Full Text] [Related]
7. [Oka varicella vaccine as a novel vaccine vector]. Shiraki K; Suzuki M Nihon Rinsho; 2006 Mar; 64 Suppl 3():340-4. PubMed ID: 16615495 [No Abstract] [Full Text] [Related]
8. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting--a pilot study. Mor M; Harel L; Kahan E; Amir J Vaccine; 2004 Dec; 23(3):325-8. PubMed ID: 15530676 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071 [TBL] [Abstract][Full Text] [Related]
15. Postexposure varicella vaccination in nine-month-old children. Kanra G; Ceyhan M; Ozmert E Pediatr Infect Dis J; 2000 Oct; 19(10):1029-30. PubMed ID: 11055616 [No Abstract] [Full Text] [Related]
16. Analysis of single nucleotide polymorphism among Varicella-Zoster Virus and identification of vaccine-specific sites. Jeon JS; Won YH; Kim IK; Ahn JH; Shin OS; Kim JH; Lee CH Virology; 2016 Sep; 496():277-286. PubMed ID: 27376245 [TBL] [Abstract][Full Text] [Related]
17. Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. Tyler SD; Peters GA; Grose C; Severini A; Gray MJ; Upton C; Tipples GA Virology; 2007 Mar; 359(2):447-58. PubMed ID: 17069870 [TBL] [Abstract][Full Text] [Related]
18. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. Loparev VN; Rubtcova E; Seward JF; Levin MJ; Schmid DS J Infect Dis; 2007 Feb; 195(4):502-10. PubMed ID: 17230409 [TBL] [Abstract][Full Text] [Related]
19. Vaccine-type mutations identified in Varicella zoster virus passaged in cell culture. Kim SC; Won YH; Park JS; Jeon JS; Ahn JH; Song MJ; Shin OS; Lee CH Virus Res; 2018 Feb; 245():62-68. PubMed ID: 29242077 [TBL] [Abstract][Full Text] [Related]
20. Development of live attenuated varicella vaccine. Gershon AA Proc Assoc Am Physicians; 1995 Oct; 107(3):365-8. PubMed ID: 8608424 [No Abstract] [Full Text] [Related] [Next] [New Search]